Journal of Cancer Research and Therapeutics Close
 

Table 2: 1st line comparative activity in terms of overall survival of Monoclonal Antibody Check Point Inhibitors in Nonsmall cell lung cancer

Table 2: 1<sup>st</sup> line comparative activity in terms of overall survival of Monoclonal Antibody Check Point Inhibitors in Nonsmall cell lung cancer